These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 3769745)
21. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
22. A child with dermatomyositis and a suspicious lymphadenopathy. Martini G; Calabrese F; Biscaro F; Zulian F J Rheumatol; 2005 Apr; 32(4):744-6. PubMed ID: 15801035 [TBL] [Abstract][Full Text] [Related]
23. [Dermatomyositis and malignancy of the pharynx (report of 3 cases)]. Wan H; Shen Z; Jin F Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1997 Dec; 11(12):540-2. PubMed ID: 10323023 [TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases. Peng JC; Sheen TS; Hsu MM Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1298-301. PubMed ID: 7576478 [TBL] [Abstract][Full Text] [Related]
25. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714 [TBL] [Abstract][Full Text] [Related]
26. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105 [TBL] [Abstract][Full Text] [Related]
27. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy. Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716 [TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805 [TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma. Kalogera-Fountzila A; Karanikolas D; Katodritis N; Samantas E; Sarafopoulos A; Ikonomou I; Zamboglou N; Tselis N; Dimitriadis AS; Fountzilas G; Strahlenther Onkol; 2006 Aug; 182(8):458-66. PubMed ID: 16896592 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma. Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824 [TBL] [Abstract][Full Text] [Related]
31. [Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)]. Gao JM; Zeng YX; Cui NJ; Lu TX; Zhao C; Xia YF; Ma J; Xie FY Ai Zheng; 2005 Oct; 24(10):1165-72. PubMed ID: 16219127 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and outcome for nasopharyngeal carcinoma. Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084 [TBL] [Abstract][Full Text] [Related]
34. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis]. Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678 [TBL] [Abstract][Full Text] [Related]
35. [Clinical analysis of 1,142 hospitalized cantonese patients with nasopharyngeal carcinoma]. Cao SM; Guo X; Li NW; Xiang YQ; Hong MH; Min HQ Ai Zheng; 2006 Feb; 25(2):204-8. PubMed ID: 16480587 [TBL] [Abstract][Full Text] [Related]
36. Dermatomyositis and malignancy: a retrospective study of 115 cases. Zhang W; Jiang SP; Huang L Eur Rev Med Pharmacol Sci; 2009; 13(2):77-80. PubMed ID: 19499841 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
38. [Clinical characters of aged nasopharyngeal carcinoma patients]. Qi SN; Xie FY; Lu TX; Gao JM; Liu MZ; Zou GR Ai Zheng; 2006 Jun; 25(6):740-3. PubMed ID: 16764772 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response. Gondhowiardjo S Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175 [TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma. Chen MK; Lai JC; Chang CC; Chang JH; Chang YJ; Chen HC Head Neck; 2008 Aug; 30(8):1052-7. PubMed ID: 18442057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]